Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia Refractory to Medical Treatment

NCT03385161 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT03385161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03385161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia Refractory to Medical Treatment
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2013
Completion date
June 30, 2017
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

botulinum toxins, type a, injection; complications, infection, male, prostatic hyperplasia, ultrasonography